Women's Health Technologies CRN Meeting
Fri, Sep 07
|FDA Building 32
Time & Location
Sep 07, 2018, 7:00 AM
FDA Building 32, 10903 New Hampshire Ave, Colesville, MD 20904, USA
About the Event
September 7, 2018 WHT CRN Meeting Recording:
Part 1: https://collaboration.fda.gov/p8s6y7dasz8/
Part 2: https://collaboration.fda.gov/p9kwl39zbpg/
Part 3: https://collaboration.fda.gov/p3j9ddv0upe/
September 7, 2018 WHT CRN Meeting Presentations:
0845-0925 A Advancing Capacity for Women’s Health (Danica Marinac-Dabic)
0845-0925 B CDRH Health of Women CRN (Terri Cornelison)
0845-0925 C National Evaluation System for Health Technologies NEST Update (Rachael Fleurence)
0925-0930 Overview of WHT CRN Work Streams (Courtney Baird)
0930-0950 Sterilization/LARC (Scott Chudnoff)
0950-1010 Pelvic Organ Prolapse (Cate Bradley & Kathleen Kobashi)
1010-1030 Uterine Fibroids (Evan Myers & Vanessa Jacoby)
1210-1230 Leveraging Claims Data to Assess Outcomes Following Hysteroscpic Sterlization (Jialin Mao)
1230-1300 SUI Registry and Discussion (Charley Rardin & Colleen Skau)
1320-1340 POP Society Perspective Catherine Bradley
1340-1345 COMPARE Overview (Evan Myers)
1345-1350 ULTRA (Vanessa Jacoby)
1350-1420 ACOG (Sean Currigan and Rebecca Allen)
1420-1510 A POP Patient Perspective (Sherrie Palm)
1420-1510 B Sterlization/LARC Patient Perspective (Beth Hodshon)
1420-1510 C UF Patient Perspective (Sateria Venable)
1520-1550 A Sterlization/LARC Manufacturer Opportunities Bayer (Alex Asiimwe)
1520-1550 B POP/SUI Manufacturer Opportunities Coloplast (Diane Brinza)
1520-1550 C UF Manufacturer Opportunities Acessa (Kim Rodriguez)